MTAP and osteosarcoma: Besides that, genomic structural variants affecting the MTAP-CDKN2A region in osteosarcoma were linked to amplified mouse double minute 2 (MDM2) expression, leading to inactivation of tumor protein p53 (TP53) and poor overall survival [64,65,66].